Navigation Links
MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,,Australia

nt manufacturing processes. The developed manufacturing methodology uses MaxCyte's proprietary platform technologies that have been described in a Master File with CBER, United States FDA and been cross- referenced in multiple clinical studies, and Medinet's technology and know-how derived from its world-leading experience in autologous cell processing resulting from marketed therapies that have been administered to over 6,000 cancer patients at Medinet's network of Contracted Medical Institutions since 1999.

About MaxCyte

MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary ex vivo cell loading technology overcomes critical obstacles such as safety, scalability and reproducibility which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its versatile technology in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases as well as in development collaborations with leading researchers. Current clinical programs with MaxCyte-engineered cells include: a Phase I/II clinical study for treatment of chronic lymphocytic leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial Hypertension (PAH). In addition there are advanced preclinical programs in oncology and regenerative medicine. More than 16 commercial and academic partners are currently using the MaxCyte technology. The MaxCyte system has an FDA Master File in place at CBER.

For more information, visit http://www.maxcyte.com.

About Medinet

Medinet is a world leading company in cell therapy supporting medical service providers in Japan. Through its service, Medinet provides medical institutions with advanced technologies and knowhow in: cell processing and culturing, qu
'"/>




Page: 1 2 3

Related medicine technology :

1. The Past, Present and Future of HLA Typing
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
10. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:1/23/2015)... 2015  Today the U.S. Food and Drug Administration (FDA) ... of serogroup B meningococcal disease in individuals ... which received FDA approval in October, represent a significant ... "I have heard over and over from ...
(Date:1/23/2015)... , Jan. 23, 2015 A lot of discussion ... methods for treating  certain illnesses, injuries, or conditions. As medical ... previous treatment methods with ones that they consider to be ... there is not one textbook method of treatment that stands ...
(Date:1/23/2015)... to Fight Chronic Disease (PFCD) released a public opinion poll of ... study analyzing the impact of increased cost sharing on patient adherence ... educate policy makers and the public on the costs of chronic ... the Iowa healthcare exchange could be improved ...
Breaking Medicine Technology:The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease 2No One-Size-Fits-All Remedy for Hernia Correction 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3
... First 23 Patients, FRAMINGHAM, Mass., SYDNEY, ... HTW), a developer of miniaturized implantable,heart pumps ... initial,results from an international clinical trial of ... were presented by Dr. Georg,Wieselthaler, cardiothoracic surgeon ...
... known that many,children get facial rashes, while teenagers tend to ... supposed to clear up., However, studies show there are ... skin conditions., Derek Lepage [spokesperson with FaceDoctor] says:, ... a,parasite, but as a bacterial infection.", "If a person ...
Cached Medicine Technology:Presentation of HeartWare Clinical Results 2Clinically Proven Treatment Offers Help to Rosacea Sufferers 2
(Date:1/23/2015)... AZ (PRWEB) January 23, 2015 Hastings and ... injury matters, reports a record number of legal representation client ... speaking, there has been a steady rise in the number ... work and at home throughout the Valley. With that said, ... accident be reviewed by an experienced law firm. Hastings and ...
(Date:1/22/2015)... Hollywood, California (PRWEB) January 22, 2015 The City ... 2015 at 10 a.m., to commemorate the 42nd anniversary of the ... United States. , “It’s been 42 years since the Roe vs. ... choose is still as present as ever,” said City of West ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Juvent Sports ... at the 2015 PGA Merchandise Show to bestow a ... incredible female amateur golfer, Arlene McKitrick. The award commemorated ... amateur golf tournament win. She won her first amateur ...
(Date:1/22/2015)... 22, 2015 Carinsurancesavings.biz has released a new ... and dismemberment insurance . , Purchasing an accidental death ... very advantageous. This type of rider provides benefits if the ... be considered a lesser form of life insurance. , ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... hypothesis, that early exposures boost immune response , WEDNESDAY, Sept. ... goes, exposes kids to more germs and illnesses at an ... on. , Scientists call it the ,hygiene hypothesis," but ... early infections have no effect on asthma and allergy rates ...
... , , FORT WORTH, Texas, Sept. 9 ... up their sneakers to walk or run in the American Cancer Society,s ... against cancer. Thanks to their efforts, more than $1 million has been ... For Life is an overnight event in which teams across the country ...
... , , , ... that 21 new communities are joining Pioneering Healthier Communities (PHC), its ... that help sustain healthy behaviors through environmental and policy change. ... Disease Control and Prevention (CDC). , , ...
... about the cancer causing effects of the second most prescribed ... to rest, following the largest ever study into their use. ... treatment for chronic acid reflux, or ,heartburn, a painful burning ... by almost a third of people in developed countries. ...
... that exposure to lead in the environment is associated ... those studies have looked at lead concentrations in blood, ... exposure over time. In a new study, researchers at ... University of Michigan School of Public Health found that ...
... , , WASHINGTON, Sept. 9 ... Medicine (HJF), in partnership with The Tug McGraw Foundation (TMF) and ... present " Country United: Advancing Medicine from the Frontlines to the ... Alliance. , , Country United is ...
Cached Medicine News:Health News:Day Care May Not Shield Kids From Asthma, Allergies 2Health News:Day Care May Not Shield Kids From Asthma, Allergies 3Health News:American Airlines Employees Raise $1 Million for American Cancer Society 2Health News:American Airlines Employees Raise $1 Million for American Cancer Society 3Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 2Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 3Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 4Health News:YMCA Expands Pioneering Healthier Communities Initiative to Lead Healthy Change in Communities Nationwide 5Health News:Major clinical study rejects cancer safety fears of most common heartburn treatment 2Health News:Lead in bone associated with increased risk of death from cardiovascular disease in men 2Health News:Tim McGraw and Faith Hill Lead Country United Effort to Benefit Military Medicine 2Health News:Tim McGraw and Faith Hill Lead Country United Effort to Benefit Military Medicine 3
... for Candida albicans in only five ... two enzyme color reactions to produce ... read. AlbiQuicktm is performed on a ... Incubation time is only five minutes ...
... Osiris is a ... management software and an ... the inhibition zone size ... Osiris offers built-in expertise ...
The Oxoid Biochemical Identification System (O.B.I.S.) albicans is a simple, non-hazardous colorimetric test for the differentiation of Candida albicans from other yeast species....
Next-generation real-time polymerase chain reaction (PCR) testing for clinical laboratories. , ,The COBAS TaqMan 48 Analyzer allows automated real-time amplification and detection of DNA or RNA f...
Medicine Products: